Harmony Biosciences Holdings Inc. (HRMY): Price and Financial Metrics


Harmony Biosciences Holdings Inc. (HRMY): $38.54

1.08 (+2.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HRMY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

HRMY Stock Price Chart Interactive Chart >

Price chart for HRMY

HRMY Price/Volume Stats

Current price $38.54 52-week high $52.74
Prev. close $37.46 52-week low $25.09
Day low $37.51 Volume 376,400
Day high $39.48 Avg. volume 236,149
50-day MA $32.19 Dividend yield N/A
200-day MA $32.79 Market Cap 2.20B

Harmony Biosciences Holdings Inc. (HRMY) Company Bio


Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.


HRMY Latest News Stream


Event/Time News Detail
Loading, please wait...

HRMY Latest Social Stream


Loading social stream, please wait...

View Full HRMY Social Stream

Latest HRMY News From Around the Web

Below are the latest news stories about Harmony Biosciences Holdings Inc that investors may wish to consider to help them evaluate HRMY as an investment opportunity.

Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced winners of the Patient at the Heart and Progress at the Heart programs in honor of the third annual World Narcolepsy Day.

Yahoo | September 22, 2021

President And CEO Of Harmony Biosciences Trades $1.10 Million In Company Stock

John Jacobs , President And CEO at Harmony Biosciences (NASDAQ: HRMY ), made a large buy and sell of company shares on September 13, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that John Jacobs purchased 25,000 Harmony Biosciences shares at a price of $8.22 per share for a total of $205,500 on September 13. They then sold their shares on the same day in the open market. They sold at a price of $35.93 to raise a total of $898,262 from the stock sale. This transaction has resulted in Jacobs no longer owning shares of the company. Harmony Biosciences Full story available on Benzinga.com

Benzinga | September 15, 2021

Notable Harmony Biosciences Insider Trades $457.98 Thousand In Company Stock

Jeffrey Dayno, Chief Medical Officer at Harmony Biosciences (NASDAQ:HRMY), made a large buy and sell of company shares on September 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 7, Jeffrey Dayno bought 10,000 Harmony Biosciences shares at a price of $8.22 per share, for a total of $82,200. They then sold their shares on the same day in the open market at a price of $37.58 to raise a total of $375,783 fr

Yahoo | September 10, 2021

Harmony Biosciences Holdings Inc (HRMY): Price Now Near $38.26; Daily Chart Shows An Uptrend on 20 Day Basis

This is a reversal of the price action on the previous hour, in which price moved up. The post Harmony Biosciences Holdings Inc (HRMY): Price Now Near $38.26; Daily Chart Shows An Uptrend on 20 Day Basis appeared first on ETF Daily News .

ETF Daily News | September 9, 2021

Harmony Biosciences Holdings Inc (HRMY): Price Up $0.53 (1.55)% Over Past Day, Up $0.11 (0.33)% Over Past Hour

It''s been a feast for bulls operating on the daily timeframe, as hrmy has now gone up 4 of the past 5 days. The post Harmony Biosciences Holdings Inc (HRMY): Price Up $0.53 (1.55)% Over Past Day, Up $0.11 (0.33)% Over Past Hour appeared first on ETF Daily News .

ETF Daily News | September 2, 2021

Read More 'HRMY' Stories Here

HRMY Price Returns

1-mo 16.33%
3-mo 30.29%
6-mo 39.84%
1-year 15.70%
3-year N/A
5-year N/A
YTD 6.61%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.1192 seconds.